Amylyx hires new CMO from Ultragenyx; Eliot Forster is back as a CEO after F-star sale

Camille Bedrosian

→ With Amylyx Pharmaceuticals’ ALS drug in full commercial swing, the Massachusetts startup has found a replacement for its chief medical officer. Camille Bedrosian will join the company from Ultragenyx, taking the place of Patrick Yeramian, whose retirement was…
Click here to view original post